Insulet Corp. (PODD) Financials

PODD Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 3.0 billion 1.7 billion
Dec. 31, 2025 3.2 billion 1.7 billion
Sept. 30, 2025 3.0 billion 1.6 billion
June 30, 2025 3.5 billion 2.0 billion

PODD Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 86.0 million 21.3 million
Dec. 31, 2025 48.2 million 20.3 million
Sept. 30, 2025 104.7 million 16.7 million
June 30, 2025 173.3 million 7.5 million

PODD Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 91.1 million
Dec. 31, 2025 101.6 million
Sept. 30, 2025 87.6 million
June 30, 2025 22.5 million

PODD Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 480.4 million 929.5 million -
Dec. 31, 2025 716.1 million 979.7 million 48.9 million
Sept. 30, 2025 757.4 million 934.9 million -
June 30, 2025 1.1 billion 939.0 million -

PODD Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 70.2 million
Dec. 31, 2025 70.7 million
Sept. 30, 2025 70.7 million
June 30, 2025 70.6 million

PODD Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 27.8 million 89.7 million 317.2 million -
Dec. 31, 2025 135.1 million 90.9 million 331.4 million -
Sept. 30, 2025 21.0 million 77.2 million 315.2 million -
June 30, 2025 23.2 million 73.4 million 257.7 million -

PODD Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 761.7 million 232.6 million
Dec. 31, 2025 783.8 million 215.2 million
Sept. 30, 2025 706.3 million 196.2 million
June 30, 2025 649.1 million 196.9 million

PODD Revenue by Segment
Graph available only for paid members. Upgrade to see it.

PODD

Price: $163.26

52 week price:
138.79
354.88

Earnings Per Share: 4.29 USD

P/E Ratio: 35.94

Exchange: NMS

Sector: Healthcare

Industry: Medical Devices

Country: United States

Volume: 334800

Ebitda: 6.4 million

Market Capitalization: 11.4 billion

Links: